Back
  1. Home
  2. Profile of Max Marc Roger Meyrath (ULiège)
Profil

Meyrath Max Marc Roger

Main Referenced Co-authors
Chevigné, Andy (12)
Szpakowska, Martyna (12)
Counson, Manuel (7)
Reynders, Nathan (6)
Hanson, Julien  (4)
Main Referenced Keywords
ACKR3 (4); chemokine receptor (2); CXCR4 (2); CXCR7 (2); ACKR1 (1);
Main Referenced Unit & Research Centers
Luxembourg Institute of Health, Department of Infection and Immunity (2)
Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (1)
Faculty of Science, Technology and Communication, University of Luxembourg (1)
Laboratory of Molecular Pharmacology, GIGA-Molecular Biology of Diseases, GIGA B34, University of Liège, (1)
Luxembourg Institute of Health (1)
Main Referenced Disciplines
Biochemistry, biophysics & molecular biology (13)
Oncology (1)
Pharmacy, pharmacology & toxicology (1)

Publications (total 14)

The most downloaded
239 downloads
Meyrath, M. M. R. (2021). New insights into the atypical chemokine receptor network and functions [Doctoral thesis, ULiège - University of Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/294394 https://hdl.handle.net/2268/294394

The most cited

77 citations (Scopus®)

Sjöberg, E., Meyrath, M. M. R., Milde, L., Herrera, M., Lövrot, J., Hägerstrand, D., Frings, O., Bartish, M., Rolny, C., Sonnhammer, E., Chevigné, A., Augsten, M., & Östman, A. (2019). A Novel ACKR2-Dependent Role of Fibroblast- Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-18-1294 https://hdl.handle.net/2268/238135

Meyrath, M. M. R. (2021). New insights into the atypical chemokine receptor network and functions [Doctoral thesis, ULiège - University of Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/294394

Meyrath, M. M. R., Szpakowska, M., Zeiner, J., Massotte, L., Merz, M. P., Benkel, T., Simon, K., Ohnmacht, J., Turner, J. D., Krüger, R., Seutin, V., Ollert, M., Kostenis, E., & Chevigné, A. (19 June 2020). The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides. Nature Communications, 11 (1), 3033. doi:10.1038/s41467-020-16664-0
Peer Reviewed verified by ORBi

Meyrath, M. M. R., Reynders, N., Uchański, T., Chevigné, A., & Szpakowska, M. (2020). Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22. Journal of Leukocyte Biology. doi:10.1002/JLB.2AB0520-275R
Peer Reviewed verified by ORBi

Sjöberg, E., Meyrath, M. M. R., Chevigné, A., Östman, A., Augsten, M., & Szpakowska, M. (2020). The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy. Advances in Cancer Research, 145, 99-138. doi:10.1016/bs.acr.2019.12.001
Peer Reviewed verified by ORBi

Wouters, E., Walraed, J., Robertson, M. J., Meyrath, M. M. R., Szpakowska, M., Chevigné, A., Skiniotis, G., & Stove, C. (2020). Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds. ACS pharmacology & translational science, 3 (2), 285-295. doi:10.1021/acsptsci.9b00069
Peer reviewed

Neirinckx, V., Hau, A.-C., Schuster, A., Fritah, S., Tiemann, K., Klein, E., Nazarov, P. V., Matagne, A., Szpakowska, M., Meyrath, M. M. R., Chevigné, A., Schmidt, M. H. H., & Niclou, S. P. (September 2019). The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein–protein interaction in glioblastoma. Neuro-Oncology Advances, 1 (1). doi:10.1093/noajnl/vdz024
Peer Reviewed verified by ORBi

Meyrath, M. M. R., Reynders, N., Counson, M., Beaupain, N., Ollert, M., Szpakowska, M., & Chevigne, A. (June 2019). NanoLuX: a network-wide Nanoluciferase-based platform to monitor activation of classical and atypical chemokine receptors [Poster presentation]. 3rd European Chemokine and Cell Migration Conference (ECMC2019), Salamanca, Spain.

Sjöberg, E., Meyrath, M. M. R., Milde, L., Herrera, M., Lövrot, J., Hägerstrand, D., Frings, O., Bartish, M., Rolny, C., Sonnhammer, E., Chevigné, A., Augsten, M., & Östman, A. (2019). A Novel ACKR2-Dependent Role of Fibroblast- Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-18-1294
Peer Reviewed verified by ORBi

Meyrath, M. M. R., Szpakowska, M., Reynders, N., Counson, M., Hanson, J., Steyaert, J., & Chevigné, A. (2018). Atypical Ligand Binding and Activation Modes of ACKR3/CXCR7 [Paper presentation]. Gordon Research Seminars, Chemotactic cytokines.

Meyrath, M. M. R., Szpakowska, M., Reynders, N., Counson, M., Hanson, J., Steyaert, J., & Chevigné, A. (28 May 2018). Distinct binding and activation modes of the atypical chemokine receptor ACKR3/CXCR7 by chemokine and endogenous non-chemokine agonists [Poster presentation]. EDT immunology day “Innate immunity in health and disease”, Liege, Sart Tilman, Belgium.

Szpakowska, M., Nevins, A. M., Meyrath, M. M. R., Rhainds, D., D'huys, T., Guité-Vinet, F., Dupuis, N., Gauthier, P.-A., Counson, M., Kleist, A., St-Onge, G., Hanson, J., Schols, D., Volkman, B., Heveker, N., & Chevigné, A. (May 2018). Different contribution of chemokine N-terminal features attest a different ligand binding mode and a bias towards activation of the atypical chemokine receptor ACKR3/CXCR7 compared to CXCR4 and CXCR3. British Journal of Pharmacology, 175 (9), 1419-1438. doi:10.1111/bph.14132
Peer Reviewed verified by ORBi

Szpakowska, M., Meyrath, M. M. R., Reynders, N., Counson, M., Hanson, J., Steyaert, J., & Chevigné, A. (2018). Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists. Biochemical Pharmacology, 153, 299-309. doi:10.1016/j.bcp.2018.03.007
Peer Reviewed verified by ORBi

Meyrath, M. M. R., Szpakowska, M., Counson, M., Reynders, N., Julien, H., Ollert, M., & Chevigné, A. (December 2017). The atypical chemokine receptor ACKR3/CXCR7 displays distinct binding and activation modes for its endogenous agonists [Poster presentation]. Luxembourg Life Sciences PhD Days 2017.

Meyrath, M. M. R., Szpakowska, M., Ollert, M., Counson, M., & Chevigné, A. (November 2016). Molecular and functional characterization of the unconventional interaction partners of CXCR7 and their role in virus-associated tumorigenesis [Poster presentation]. Luxembourg Life Science PhD Days 2016, Esch-sur-alzette, Luxembourg.

Contact ORBi